These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 31669135)

  • 1. Educational Material on Prostate Cancer Screening is Overly Complex and Fails to Meet Recommended Layperson Readability Guidelines.
    Rooney MK; Morgans AK; Chen RC; Golden DW; Meeks JJ; Auffenberg G; Kundu SD; Schaeffer EM; Hussain MH; Kalapurakal JA; Sachdev S
    Urology; 2020 Jan; 135():1-3. PubMed ID: 31669135
    [No Abstract]   [Full Text] [Related]  

  • 2. Long-term consequences of the USPSTF Grade D recommendation for prostate-specific antigen screening.
    Joshi SS; Filson CP
    Cancer; 2020 Feb; 126(4):694-696. PubMed ID: 31794066
    [No Abstract]   [Full Text] [Related]  

  • 3. Prostate cancer incidence across stage, NCCN risk groups, and age before and after USPSTF Grade D recommendations against prostate-specific antigen screening in 2012.
    Butler SS; Muralidhar V; Zhao SG; Sanford NN; Franco I; Fullerton ZH; Chavez J; D'Amico AV; Feng FY; Rebbeck TR; Nguyen PL; Mahal BA
    Cancer; 2020 Feb; 126(4):717-724. PubMed ID: 31794057
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pendulum swings back: Screening for prostate cancer in 2018.
    Thompson IM
    Cancer; 2018 Jul; 124(13):2690-2692. PubMed ID: 29786846
    [No Abstract]   [Full Text] [Related]  

  • 5. Similar perspectives on prostate cancer screening value and new guidelines across patient demographic and PSA level subgroups: A qualitative study.
    Partin MR; Lillie SE; White KM; Wilt TJ; Chrouser KL; Taylor BC; Burgess DJ
    Health Expect; 2017 Aug; 20(4):779-787. PubMed ID: 27807905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recent Patterns of Prostate-Specific Antigen Testing for Prostate Cancer Screening in the United States.
    Fedewa SA; Ward EM; Brawley O; Jemal A
    JAMA Intern Med; 2017 Jul; 177(7):1040-1042. PubMed ID: 28437537
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Evolving detection and treatment methods change approaches to prostate cancer: US Preventive Services Task Force draft recommendations now align more closely with others.
    Printz C
    Cancer; 2018 Jan; 124(1):11-12. PubMed ID: 29251768
    [No Abstract]   [Full Text] [Related]  

  • 8. Impact of health literacy on shared decision making for prostate-specific antigen screening in the United States.
    Nguyen DD; Trinh QD; Cole AP; Kilbridge KL; Mahal BA; Hayn M; Hansen M; Han PKJ; Sammon JD
    Cancer; 2021 Jan; 127(2):249-256. PubMed ID: 33165954
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Counseling Patients About Prostate Cancer Screening.
    Stevermer JJ; Fink KS
    Am Fam Physician; 2018 Oct; 98(8):478-483. PubMed ID: 30277734
    [No Abstract]   [Full Text] [Related]  

  • 10. Impact of the 2008 US Preventive Services Task Force recommendation to discontinue prostate cancer screening among male Medicare beneficiaries.
    Ross JS; Wang R; Long JB; Gross CP; Ma X
    Arch Intern Med; 2012 Nov; 172(20):1601-3. PubMed ID: 22987029
    [No Abstract]   [Full Text] [Related]  

  • 11. Prostate-specific antigen test for prostate cancer screening: American Society of Clinical Oncology provisional clinical opinion.
    Nam RK; Oliver TK; Vickers AJ; Thompson I; Kantoff PW; Parnes HL; Loblaw A; Roth BJ; Williams J; Temin S; Basch E
    J Oncol Pract; 2012 Sep; 8(5):315-7. PubMed ID: 23277770
    [No Abstract]   [Full Text] [Related]  

  • 12. Stratifying risk--the U.S. Preventive Services Task Force and prostate-cancer screening.
    Schröder FH
    N Engl J Med; 2011 Nov; 365(21):1953-5. PubMed ID: 22029756
    [No Abstract]   [Full Text] [Related]  

  • 13. PSA cancer screening: a case for shared decision-making.
    Dasarathy J; Rajesh R
    J Fam Pract; 2020; 69(1):26;28;30;32;46. PubMed ID: 32017831
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prostate-cancer screening--what the U.S. Preventive Services Task Force left out.
    Brett AS; Ablin RJ
    N Engl J Med; 2011 Nov; 365(21):1949-51. PubMed ID: 22029759
    [No Abstract]   [Full Text] [Related]  

  • 15. Prostate cancer: Draft USPSTF 2017 recommendation on PSA testing - a sea-change?
    Van der Kwast TH; Roobol MJ
    Nat Rev Urol; 2017 Aug; 14(8):457-458. PubMed ID: 28607501
    [No Abstract]   [Full Text] [Related]  

  • 16. Navigating Prostate Cancer Screening in the Real World of Primary Care: The Mirage and the Quicksand.
    Mathew P; Hachem H; Han P
    JAMA Oncol; 2018 Apr; 4(4):453-454. PubMed ID: 29470576
    [No Abstract]   [Full Text] [Related]  

  • 17. American Urological Association (AUA) guideline on prostate cancer detection: process and rationale.
    Carter HB
    BJU Int; 2013 Sep; 112(5):543-7. PubMed ID: 23924423
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One man at a time--resolving the PSA controversy.
    McNaughton-Collins MF; Barry MJ
    N Engl J Med; 2011 Nov; 365(21):1951-3. PubMed ID: 22029758
    [No Abstract]   [Full Text] [Related]  

  • 19. Prostate cancer screening.
    Ragsdale JW; Halstater B; Martinez-Bianchi V
    Prim Care; 2014 Jun; 41(2):355-70. PubMed ID: 24830612
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Re: Prostate Cancer Incidence 5 Years After US Preventive Services Task Force Recommendations Against Screening.
    Lehrer S; Rheinstein PH
    J Natl Cancer Inst; 2020 Oct; 112(10):1067-1068. PubMed ID: 32602898
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.